TrialOpen forum infectious diseases2024

Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.

Annalisa Marinosci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.